Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Her2/neu (654-662) Gp2
2. 160790-21-6
3. (2s)-2-[[(2s,3s)-2-[[2-[[(2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-[[(2s,3s)-2-[[(2s,3s)-2-amino-3-methylpentanoyl]amino]-3-methylpentanoyl]amino]-3-hydroxypropanoyl]amino]propanoyl]amino]-3-methylbutanoyl]amino]-3-methylbutanoyl]amino]acetyl]amino]-3-methylpentanoyl]amino]-4-methylpentanoic Acid
4. Gp2 Peptide
5. Unii-fqa52pv28g
6. Fqa52pv28g
7. Hy-p1855
8. Ncgc00167173-01
9. Cs-0096586
10. L-isoleucyl-l-isoleucyl-l-seryl-l-alanyl-l-valyl-l-valylglycyl-l-isoleucyl-l-leucine
11. L-leucine, L-isoleucyl-l-isoleucyl-l-seryl-l-alanyl-l-valyl-l-valylglycyl-l-isoleucyl-
12. (2s,5s,11s,14s,17s,20s,23s,26s,27s)-26-amino-5,23-di-sec-butyl-20-(hydroxymethyl)-2-isobutyl-11,14-diisopropyl-17,27-dimethyl-4,7,10,13,16,19,22,25-octaoxo-3,6,9,12,15,18,21,24-octaazanonacosan-1-oic Acid
| Molecular Weight | 884.1 g/mol |
|---|---|
| Molecular Formula | C42H77N9O11 |
| XLogP3 | 0.4 |
| Hydrogen Bond Donor Count | 11 |
| Hydrogen Bond Acceptor Count | 12 |
| Rotatable Bond Count | 28 |
| Exact Mass | 883.57425431 g/mol |
| Monoisotopic Mass | 883.57425431 g/mol |
| Topological Polar Surface Area | 316 Ų |
| Heavy Atom Count | 62 |
| Formal Charge | 0 |
| Complexity | 1530 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 11 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A GP2 Peptide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of GP2 Peptide, including repackagers and relabelers. The FDA regulates GP2 Peptide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. GP2 Peptide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A GP2 Peptide supplier is an individual or a company that provides GP2 Peptide active pharmaceutical ingredient (API) or GP2 Peptide finished formulations upon request. The GP2 Peptide suppliers may include GP2 Peptide API manufacturers, exporters, distributors and traders.
GP2 Peptide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of GP2 Peptide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right GP2 Peptide GMP manufacturer or GP2 Peptide GMP API supplier for your needs.
A GP2 Peptide CoA (Certificate of Analysis) is a formal document that attests to GP2 Peptide's compliance with GP2 Peptide specifications and serves as a tool for batch-level quality control.
GP2 Peptide CoA mostly includes findings from lab analyses of a specific batch. For each GP2 Peptide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
GP2 Peptide may be tested according to a variety of international standards, such as European Pharmacopoeia (GP2 Peptide EP), GP2 Peptide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (GP2 Peptide USP).
LOOKING FOR A SUPPLIER?
